|
Marché Fermé -
OTC Markets
16:54:58 03/06/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,0770 USD | -.--% |
|
+7,54% | -16,75% |
| 29/08/25 | Altamira Therapeutics Ltd. publie ses résultats semestriels au 30 juin 2025 | CI |
| 29/08/25 | Transcript : Altamira Therapeutics Ltd., H1 2025 Earnings Call, Aug 29, 2025 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -.--% | +7,54% | -8,33% | -20,59% | -16,75% | +28,33% | -98,43% | -99,99% | -100,00% | 429 k | ||
| -2,33% | +0,53% | +0,03% | -3,53% | +7,67% | +51,65% | +115,42% | +400,79% | +1 341,66% | 1 031 Md | ||
| -1,06% | -1,65% | -0,42% | +4,24% | +27,92% | +42,78% | +69,98% | +63,93% | +124,11% | 638 Md | ||
| -0,65% | -1,32% | +2,02% | +3,95% | +14,49% | +12,98% | +75,49% | +142,50% | +314,76% | 462 Md | ||
| -2,66% | -1,87% | -1,66% | +13,08% | +38,05% | +73,13% | +41,15% | +93,46% | +132,83% | 359 Md | ||
| -0,54% | -4,51% | -0,14% | +5,54% | +5,73% | +22,92% | +39,89% | +0,51% | +43,57% | 335 Md | ||
| -1,49% | -0,62% | -9,73% | -5,42% | +7,86% | +13,65% | +26,61% | +55,43% | +53,73% | 273 Md | ||
| -1,88% | -2,63% | +0,94% | -12,85% | -12,44% | -2,91% | +10,26% | +37,63% | +139,52% | 253 Md | ||
| -0,50% | +3,80% | -1,95% | +16,40% | +28,78% | +49,37% | +56,84% | +98,22% | +152,69% | 228 Md | ||
| -1,47% | -1,53% | +1,85% | +17,98% | +21,44% | +34,28% | +98,89% | +113,39% | +88,38% | 185 Md | ||
| -1,93% | -1,90% | -15,55% | -23,40% | -23,69% | -32,29% | -61,02% | -19,02% | +82,84% | 170 Md | ||
| -0,70% | +1,21% | +0,21% | +18,44% | +14,54% | +11,93% | -14,02% | -33,69% | -15,80% | 163 Md | ||
| -0,74% | +1,25% | -3,99% | +5,25% | +15,32% | +33,49% | +50,35% | +188,22% | +499,48% | 133 Md | ||
| -0,73% | +2,04% | -6,60% | +8,30% | +15,68% | +38,36% | +7,51% | +5,46% | +15,73% | 127 Md | ||
| -1,27% | -3,03% | -3,56% | +13,00% | +4,09% | +10,52% | +96,35% | +328,23% | +412,03% | 99,55 Md | ||
| -1,56% | -3,68% | -3,39% | -6,32% | -0,90% | +8,17% | +21,83% | +4,39% | -13,13% | 97,46 Md | ||
| +0,76% | +1,39% | -4,89% | +0,07% | -11,63% | -14,18% | -28,21% | -11,51% | +7,12% | 98,83 Md | ||
| -5,35% | +5,74% | +37,22% | +174,98% | +553,00% | +645,53% | +86,44% | -49,96% | - | 76,88 Md | ||
| +1,03% | -5,43% | -5,11% | +21,61% | -1,76% | +34,86% | -7,86% | +25,30% | +88,61% | 75,72 Md | ||
| -1,57% | +1,49% | -2,72% | -5,92% | +10,89% | +12,87% | -12,01% | -25,71% | +40,95% | 68,18 Md | ||
| Moyenne | -0,82% | +0,04% | -1,29% | +11,24% | +34,91% | +53,77% | +28,77% | +65,88% | +179,43% | 243,66 Md | |
| Moyenne pondérée par Capi. | -1,05% | -0,14% | -1,09% | +5,32% | +20,96% | +41,12% | +56,83% | +136,85% | +396,43% |
- Bourse
- Actions
- Action CYTOF
- Secteur Altamira Therapeutics Ltd.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















